LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

Search

Phibro Animal Health Corp

Geschlossen

BrancheGesundheitswesen

44.92 -0.35

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

43.91

Max

46.05

Schlüsselkennzahlen

By Trading Economics

Einkommen

9.3M

27M

Verkäufe

-15M

364M

KGV

Branchendurchschnitt

27.443

105.69

EPS

0.73

Dividendenrendite

1.1

Gewinnspanne

7.29

Angestellte

2,475

EBITDA

11M

51M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

-11.86% downside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.10%

2.37%

Nächste Dividendenausschüttung

17. Dez. 2025

Nächstes Ex-Dividendendatum

26. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

100M

1.9B

Vorheriger Eröffnungskurs

45.27

Vorheriger Schlusskurs

44.92

Nachrichtenstimmung

By Acuity

27%

73%

67 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Phibro Animal Health Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

17. Nov. 2025, 18:59 UTC

Wichtige Markttreiber

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

17. Nov. 2025, 23:40 UTC

Market Talk

Gold Consolidates Amid Mixed Signals -- Market Talk

17. Nov. 2025, 23:34 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

17. Nov. 2025, 22:58 UTC

Market Talk

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

17. Nov. 2025, 22:46 UTC

Market Talk

Risk Assets Set to Have a Strong 2026 -- Market Talk

17. Nov. 2025, 22:06 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

17. Nov. 2025, 22:02 UTC

Ergebnisse

Trip.com Group 3Q Rev $2.6B >TCOM

17. Nov. 2025, 22:02 UTC

Ergebnisse

Trip.com Group 3Q Adj EPS $3.87 >TCOM

17. Nov. 2025, 22:02 UTC

Ergebnisse

Trip.com Group 3Q EPS $4.02 >TCOM

17. Nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. Nov. 2025, 21:40 UTC

Ergebnisse

James Hardie Industries 2Q Adj EPS 26c >JHX

17. Nov. 2025, 21:40 UTC

Ergebnisse

James Hardie Industries 2Q Loss/Shr 10c >JHX

17. Nov. 2025, 21:39 UTC

Ergebnisse

James Hardie Industries 2Q Sales $1.29B >JHX

17. Nov. 2025, 21:38 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17. Nov. 2025, 21:38 UTC

Ergebnisse

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

17. Nov. 2025, 21:10 UTC

Ergebnisse

XP Inc. 3Q EPS BRL2.47 >XP

17. Nov. 2025, 21:10 UTC

Ergebnisse

XP Inc. 3Q Rev BRL4.67B >XP

17. Nov. 2025, 20:20 UTC

Market Talk

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

17. Nov. 2025, 20:12 UTC

Market Talk

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

17. Nov. 2025, 20:12 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. Nov. 2025, 20:09 UTC

Market Talk

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

17. Nov. 2025, 19:29 UTC

Market Talk

Gold Slide Continues to Start Week -- Market Talk

17. Nov. 2025, 19:16 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17. Nov. 2025, 18:20 UTC

Akquisitionen, Fusionen, Übernahmen

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

17. Nov. 2025, 16:45 UTC

Akquisitionen, Fusionen, Übernahmen

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

17. Nov. 2025, 16:16 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17. Nov. 2025, 16:15 UTC

Ergebnisse

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

17. Nov. 2025, 15:40 UTC

Akquisitionen, Fusionen, Übernahmen

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

17. Nov. 2025, 15:22 UTC

Akquisitionen, Fusionen, Übernahmen

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

17. Nov. 2025, 15:19 UTC

Market Talk

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

Peer-Vergleich

Kursveränderung

Phibro Animal Health Corp Prognose

Kursziel

By TipRanks

-11.86% Nachteil

12-Monats-Prognose

Durchschnitt 39.75 USD  -11.86%

Hoch 50 USD

Tief 27 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Phibro Animal Health Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

4 ratings

1

Buy

2

Halten

1

Sell

Technischer Score

By Trading Central

17 / N/AUnterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Weak Bearish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

67 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
help-icon Live chat